In the BioHarmony Drug Report Database
Tafenoquine
Arakoda, Krintafel (tafenoquine) is a small molecule pharmaceutical. Tafenoquine was first approved as Arakoda on 2018-07-20. It is used to treat malaria in the USA. Arakoda’s patent is valid until 2035-12-02 (FDA).
Trade Name
|
Arakoda, Krintafel |
|---|---|
Common Name
|
tafenoquine |
ChEMBL ID
|
CHEMBL298470 |
Indication
|
malaria |
Drug Class
|
Antimalarial |
Image (chem structure or protein)